approval · primary record
ELAMIPRETIDE HYDROCHLORIDE
FDA · NDA · 2025-09-19
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-09-19 |
| Brand | FORZINITY |
| Sponsor | STEALTH BIOTHERAPS |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:39.942Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ELAMIPRETIDE HYDROCHLORIDE:2025-09-19
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.